Literature DB >> 7848301

Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP.

M H Wu1, C Y Lam, B Y Yung.   

Abstract

The movement of nucleophosmin from nucleoli to nucleoplasm in HeLa cells induced by cytotoxic drugs and detected by immunofluorescence is inhibited by concomitant treatment with antimycin A in glucose-free medium. Incubation of HeLa cells with antimycin A (300 nM; 30 min) and glucose-free medium resulted in an approximately 90% decrease in cellular ATP pools. To study the biochemical events involved in nucleophosmin translocation, we used an in vitro system consisting of Triton-permeabilized HeLA cells. Incubation of permeabilized cells with ATP (0.5 mM; 1 h) resulted in the translocation of nucleophosmin from nucleoli to nucleoplasm and cytoplasm. Similarly to drug-induced nucleophosmin translocation in whole cultured cells, there is no reduction (measured by e.l.i.s.a.) or degradation of nucleophosmin or change in the ratio of the high-molecular-mass form to the monomeric form (ascertained by Western blotting) during ATP treatment of permeabilized cells. Together, these results indicate a requirement for ATP for redistribution of nucleophosmin from nucleoli to nucleoplasm. Because this permeabilized cell model is simple and efficient and works effectively with exogenous factors, it should provide a powerful tool for investigating the biochemical features of nucleophosmin translocation from nucleoli to nucleoplasm.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7848301      PMCID: PMC1136355          DOI: 10.1042/bj3050987

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Demonstration of an unstable RNA and of a precursor to ribosomal RNA in HeLa cells.

Authors:  K SCHERRER; H LATHAM; J E DARNELL
Journal:  Proc Natl Acad Sci U S A       Date:  1963-02-15       Impact factor: 11.205

2.  Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.

Authors:  B Y Yung; A M Bor; P K Chan
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

3.  Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.

Authors:  B Y Yung; Y H Yang; A M Bor
Journal:  Int J Cancer       Date:  1991-07-09       Impact factor: 7.396

4.  Comparison of proteins of ribosomal subunits and nucleolar preribosomal particles from Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis.

Authors:  A W Prestayko; G R Klomp; D J Schmoll; H Busch
Journal:  Biochemistry       Date:  1974-04-23       Impact factor: 3.162

5.  In the absence of ribosomal RNA synthesis, the ribosomal proteins of HeLa cells are synthesized normally and degraded rapidly.

Authors:  J R Warner
Journal:  J Mol Biol       Date:  1977-09-25       Impact factor: 5.469

6.  Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60.

Authors:  B Y Yung; K J Luo; E K Hui
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

7.  Assembly of nucleosomes: the reaction involving X. laevis nucleoplasmin.

Authors:  W C Earnshaw; B M Honda; R A Laskey; J O Thomas
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

8.  Phosphoprotein B23 translocation and modulation of actinomycin D and doxorubicin cytotoxicity by dipyridamole in HeLa cells.

Authors:  A M Bor; F J Chang; B Y Yung
Journal:  Int J Cancer       Date:  1992-10-21       Impact factor: 7.396

9.  A constitutive nucleolar protein identified as a member of the nucleoplasmin family.

Authors:  M S Schmidt-Zachmann; B Hügle-Dörr; W W Franke
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

10.  Nucleoplasmin cDNA sequence reveals polyglutamic acid tracts and a cluster of sequences homologous to putative nuclear localization signals.

Authors:  C Dingwall; S M Dilworth; S J Black; S E Kearsey; L S Cox; R A Laskey
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

View more
  9 in total

1.  Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition.

Authors:  Yaron Shav-Tal; Janna Blechman; Xavier Darzacq; Cristina Montagna; Billy T Dye; James G Patton; Robert H Singer; Dov Zipori
Journal:  Mol Biol Cell       Date:  2005-03-09       Impact factor: 4.138

2.  Immunodetection of nucleolar proteins and ultrastructure of nucleoli of soybean root meristematic cells treated with chilling stress and after recovery.

Authors:  Dariusz Stepiński
Journal:  Protoplasma       Date:  2009-02-25       Impact factor: 3.356

3.  Nucleolar changes and fibrillarin redistribution following apatone treatment of human bladder carcinoma cells.

Authors:  James M Jamison; Jacques Gilloteaux; Laszlo Perlaky; Marc Thiry; Karel Smetana; Deborah Neal; Karen McGuire; Jack L Summers
Journal:  J Histochem Cytochem       Date:  2010-04-12       Impact factor: 2.479

4.  Evidence for the ability of nucleophosmin/B23 to bind ATP.

Authors:  J H Chang; J Y Lin; M H Wu; B Y Yung
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

5.  Reconstitution of HIV-1 rev nuclear export: independent requirements for nuclear import and export.

Authors:  D C Love; T D Sweitzer; J A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 6.  Inflammation and endothelial dysfunction during aging: role of NF-kappaB.

Authors:  Anna Csiszar; Mingyi Wang; Edward G Lakatta; Zoltan Ungvari
Journal:  J Appl Physiol (1985)       Date:  2008-07-03

7.  Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer region.

Authors:  P K Chan; F Y Chan; S W Morris; Z Xie
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

8.  Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.

Authors:  Suwit Duangmano; Phorntip Sae-Lim; Apichart Suksamrarn; Frederick E Domann; Pimpicha Patmasiriwat
Journal:  BMC Complement Altern Med       Date:  2012-10-12       Impact factor: 3.659

9.  Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD.

Authors:  Nadja S Andrade; Melina Ramic; Rustam Esanov; Wenjun Liu; Mathew J Rybin; Gabriel Gaidosh; Abbas Abdallah; Samuel Del'Olio; Tyler C Huff; Nancy T Chee; Sadhana Anatha; Tania F Gendron; Claes Wahlestedt; Yanbin Zhang; Michael Benatar; Christian Mueller; Zane Zeier
Journal:  Mol Neurodegener       Date:  2020-02-24       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.